$Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin®) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas$

Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin®) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas

Bibliographic Details
Main Authors:	Songül Şerefhanoğlu, Ebru Koca, Hakan Goker, İbrahim Celalettin Haznedaroğlu, Deniz Çetiner, Nilgün Sayınalp, Yahya Büyükaşık, Osman İlhami Özcebe
Format:	Article
Language:	English
Published:	Galenos Publishing House 2008-12-01
Series:	Turkish Journal of Hematology
Subjects:	Ibritumomab Tiuxetan Radioimmunotherapy NHL
Online Access:	https://www.journalagent.com/z4/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-16443

Similar Items

Analisi costi-efficacia di 90Y-ibritumomab tiuxetano (Zevalin®) vs. terapie attualmente disponibili nel trattamento dei pazienti affetti da Linfoma Non-Hodgkin (LNH) refrattario o recidivato
by: Carlo Lazzaro, et al.
Published: (2005-12-01)

90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases
by: Wang J, et al.
Published: (2023-10-01)

Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma
by: Ollila TA, et al.
Published: (2021-05-01)

Dynamic Metabolic Changes during the First 3 Months after 90Y-Ibritumomab Tiuxetan Radioimmunotherapy
by: Miwako Takahashi, et al.
Published: (2014-01-01)

Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
by: McKinney MS, et al.
Published: (2014-08-01)

Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan
by: Shinobu Tamura, et al.
Published: (2013-01-01)

Antibody conjugate radioimmunotherapy of superficial bladder cancer
by: Alan Perkins, et al.
Published: (2002-09-01)

RADIOIMMUNOTHERAPY IN THE TREATMENT OF MALIGNANCIES
by: V. I. Chernov, et al.
Published: (2016-07-01)

Radioimmunotherapy: future prospects from the perspective of brachytherapy
by: Maximilian Fleischmann, et al.
Published: (2021-08-01)

90Y-ibritumomab Tiuxetan in B-cell Non-Hodgkin Lymphomas: Real-world Data From the United Arab Emirates
by: Zsolt Szakács, MD, PhD, et al.
Published: (2022-09-01)

Environmental management activities of NHL teams
by: Laura Márton
Published: (2022-06-01)

Environmental management activities of NHL teams
by: Laura Márton
Published: (2022-06-01)

Subcutaneous Panniculitis-Like T-Cell Lymphoma with Hemophagocytic Syndrome in a Child: A Successful Treatment with the BFM-NHL-90 Protocol
by: Sunjoo Kim, et al.
Published: (2020-10-01)

Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma
by: Hiroki Goto, et al.
Published: (2024-02-01)

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
by: Mark Hertzberg, et al.
Published: (2017-02-01)

Immunohistochemical expression of VEGF in relation to VEGFR and CD34 in NHL using digital image analysis system
by: Bassam Mohammad Hameed, et al.
Published: (2016-01-01)

Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin&rsquo;s lymphoma
by: Christos Emmanouilides
Published: (2009-10-01)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
by: Udo S. Gaipl, et al.
Published: (2020-02-01)

Optimizing Cancer Treatment: Exploring the Role of AI in Radioimmunotherapy
by: Hossein Azadinejad, et al.
Published: (2025-02-01)

Country of Origin Effects on the Average Annual Values of NHL Player Contracts
by: Aju J. Fenn, et al.
Published: (2019-05-01)

NHL Heavyweights: Narratives of Violence and Masculinity in Ice Hockey
by: Tjønndal Anne
Published: (2016-06-01)

Ibritumomab tiuxetan plus BEAM in refractory diffuse large B-cell lymphoma
by: Vít Procházka, et al.
Published: (2014-07-01)

Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer
by: Mei Zhu, et al.
Published: (2023-03-01)

Clinicopathologic Profile and Outcome of Extranodal Diffuse Large B-Cell NHL: Egyptian National Cancer Institute Experience
by: Khorshed Ola, et al.
Published: (2015-09-01)

Radioimmunotherapy of lymphoma
by: Goldsmith Stanley J.
Published: (2012-01-01)

Variations in the physical and mechanical behavior of basalt fiber reinforced NHL mortars exposed to different curing conditions
by: Purificación Bautiste Villanueva, et al.
Published: (2024-12-01)

Radioimmunotherapy combating biofilm-associated infection in vitro
by: Zijian Ye, et al.
Published: (2024-11-01)

Experimental and clinical approaches to a radioimmunotherapy in o
by: E. V. Abakushina, et al.
Published: (2016-02-01)

Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry
by: Otto C. Boerman
Published: (2014-11-01)

Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy
by: Weronika Gawęda, et al.
Published: (2020-10-01)

Development of In Vitro Assays for Advancing Radioimmunotherapy against Brain Tumors
by: Yohan Walter, et al.
Published: (2022-07-01)

Near-Infrared Light-Responsive Nitric Oxide Delivery Platform for Enhanced Radioimmunotherapy
by: Xuanfang Zhou, et al.
Published: (2020-04-01)

The TRIM-NHL protein NHL-2 is a co-factor in the nuclear and somatic RNAi pathways in C. elegans
by: Gregory M Davis, et al.
Published: (2018-12-01)

Assessment and modulation of chemoresistance by different sub-groups of chemosensitizers in a NHL cell line model
by: Behzad Foroutan, et al.
Published: (2012-09-01)

Pilot experience of using modified high-dose therapy NHL-BFM-90 in diffuse large B-cell lymphosarcoma with primary skin involvement. A case report
by: Varvara Ivanovna Zamyatina, et al.
Published: (2009-07-01)

Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer
by: Hanghang Yuan, et al.
Published: (2023-01-01)

STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer
by: Lei Wang, et al.
Published: (2024-02-01)

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients
by: Caroline eBodet-Milin, et al.
Published: (2015-11-01)

Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
by: Weijun Wei, et al.
Published: (2020-07-01)

Radioimmunotherapy of B-cell non-Hodgkin’s lymphoma
by: Caroline eBodet-Milin, et al.
Published: (2013-07-01)